Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$828K Sell
2,286
-315
-12% -$108K 0.09% 85
2026
Q1
$915K Sell
2,601
-1,874
-42% -$668K 0.11% 73
2025
Q4
$1.46M Sell
4,475
-383
-8% -$121K 0.18% 57
2025
Q3
$1.37M Buy
4,858
+82
+2% +$23.8K 0.18% 55
2025
Q2
$1.33M Buy
4,776
+263
+6% +$74.5K 0.2% 50
2025
Q1
$1.41M Buy
4,513
+912
+25% +$269K 0.25% 45
2024
Q4
$939K Buy
3,601
+907
+34% +$269K 0.17% 61
2024
Q3
$868K Sell
2,694
-182
-6% -$59.5K 0.16% 72
2024
Q2
$898K Sell
2,876
-39
-1% -$11.5K 0.19% 63
2024
Q1
$829K Buy
2,915
+1,260
+76% +$369K 0.18% 67
2023
Q4
$477K Sell
1,655
-503
-23% -$137K 0.13% 79
2023
Q3
$580K Buy
2,158
+511
+31% +$128K 0.17% 61
2023
Q2
$366K Sell
1,647
-30
-2% -$6.96K 0.12% 86
2023
Q1
$405K Buy
1,677
+95
+6% +$23.3K 0.12% 78
2022
Q4
$415K Buy
1,582
+77
+5% +$20.6K 0.12% 83
2022
Q3
$339K Sell
1,505
-10
-0.7% -$2.42K 0.1% 88
2022
Q2
$369K Sell
1,515
-9
-0.6% -$2.21K 0.1% 83
2022
Q1
$369K Sell
1,524
-251
-14% -$57.7K 0.09% 95
2021
Q4
$402K Sell
1,775
-348
-16% -$73.4K 0.12% 93
2021
Q3
$451K Sell
2,123
-2
-0.1% -$460 0.15% 76
2021
Q2
$518K Buy
2,125
+7
+0.3% +$1.72K 0.17% 69
2021
Q1
$527K Sell
2,118
-15
-0.7% -$3.58K 0.21% 59
2020
Q4
$490K Buy
+2,133
New +$492K 0.21% 61

Other funds holding AMGN

MJP Associates's AMGN Position: Q2 2026 in Review

MJP Associates reduced its Amgen (AMGN) stake by 12% in Q2 2026, selling an estimated $108K and leaving 2,286 shares worth $828K. The position accounts for 0.09% of the portfolio, ranked #85.

MJP Associates first reported a position in AMGN in Q4 2020 and has held it in 23 quarters since. The position peaked at $1.46M in Q4 2025. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • MJP Associates held 2,286 shares of Amgen worth $828K as of Q2 2026.
  • MJP Associates sold 315 Amgen shares in Q2 2026, an estimated $108K.
  • Amgen made up 0.09% of MJP Associates's portfolio in Q2 2026, its #85 holding.
  • MJP Associates first reported a position in Amgen in Q4 2020 and has held it in 23 quarters since.
  • MJP Associates's Amgen position peaked at $1.46M in Q4 2025.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on MJP Associates's 13F filing for Q2 2026, filed 11 Aug 2026.